Strides Pharma Science Limited — Emtricitabine Exporter Profile
Indian Pharmaceutical Exporter · #9 for Emtricitabine · $650.0K export value · DGFT Verified
Strides Pharma Science Limited is the #9 Indian exporter of Emtricitabine with $650.0K in export value and 13 verified shipments. Strides Pharma Science Limited holds a 0.6% market share in Emtricitabine exports across 6 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Emtricitabine Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Emtricitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $277.0K | 7 | 63.5% |
| INDONESIA | $50.0K | 1 | 11.5% |
| UNITED STATES | $50.0K | 1 | 11.5% |
| COSTA RICA | $50.0K | 1 | 11.5% |
| BANGLADESH | $6.0K | 1 | 1.4% |
| YEMEN, DEMOCRATIC | $3.3K | 2 | 0.8% |
Strides Pharma Science Limited exports Emtricitabine to 6 countries. The largest destination is MEXICO accounting for 63.5% of Strides Pharma Science Limited's Emtricitabine shipments, followed by INDONESIA (11.5%) and UNITED STATES (11.5%). These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Emtricitabine from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALTERNAVIDA SA DE CV | MEXICO | $150.0K | 3 |
| ALTERNAVIDA S A DE C V | MEXICO | $77.0K | 3 |
| SEKRETARIAT DITJJEN PENCEGAHAN DAN | INDONESIA | $50.0K | 1 |
| STRIDES PHARMA INC | UNITED STATES | $50.0K | 1 |
| CAJA COSTARRICENSE DE SEGURO SOCIAL | COSTA RICA | $50.0K | 1 |
| ALTERNAVIDA SA DE | MEXICO | $50.0K | 1 |
| TO THE ORDER OF AGRANI BANK LIMITED | BANGLADESH | $6.0K | 1 |
| INTERNATIONAL ORGANISATION FOR MIGR | YEMEN, DEMOCRATIC | $2.5K | 1 |
| INTERNATIONAL ORGANISATION FOR | YEMEN, DEMOCRATIC | $731 | 1 |
Strides Pharma Science Limited supplies Emtricitabine to 9 buyers globally. The largest buyer is ALTERNAVIDA SA DE CV (MEXICO), followed by ALTERNAVIDA S A DE C V (MEXICO) and SEKRETARIAT DITJJEN PENCEGAHAN DAN (INDONESIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Emtricitabine Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $51.2M worth of Emtricitabine through 2,194 shipments from 141 suppliers to 117 countries, serving 493 buyers globally. Strides Pharma Science Limited contributes $650.0K to this total, accounting for 0.6% of India's Emtricitabine exports. Strides Pharma Science Limited ships Emtricitabine to 6 countries through 9 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Emtricitabine Exports?
Strides Pharma Science Limited's average Emtricitabine shipment value is $50.0K per consignment, based on 13 shipments totaling $650.0K. The largest destination is MEXICO (63.5% of Strides Pharma Science Limited's Emtricitabine exports).
How Does Strides Pharma Science Limited Compare to Other Indian Emtricitabine Exporters?
Strides Pharma Science Limited ranks #9 among 141 Indian Emtricitabine exporters with a 0.6% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($14.0M), MYLAN LABORATORIES LIMITED ($13.3M), AUROBINDO PHARMA LTD ($5.9M). Strides Pharma Science Limited processed 13 shipments to 6 destination countries.
What Emtricitabine Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 200 300MG FC 37344X 30S | $100.0K | 2 |
| Emtricitabine and Tenofovir Disoproxil F | $77.0K | 3 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL F | $58.5K | 3 |
| EMTRICITABINE IH (LAURUS LABS) (460 X IH | $50.0K | 1 |
| EFAVIRENZ,EMTRICITABINE AND TENOFOVIR DI | $50.0K | 1 |
| Emtricitabine and Tenofovir Disoproxil Fumarate Tablets [200/300mg] 36564.00 X30'S | $50.0K | 1 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS [200/300MG] 36,564.00 X30'S | $50.0K | 1 |
| Efavirenz, Emtricitabine and Tenofovir D | $731 | 1 |
Strides Pharma Science Limited exports 8 distinct Emtricitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 200 with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Emtricitabine to Key Markets
What Strides Pharma Science Limited must comply with to export Emtricitabine to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Strides Pharma Science Limited Compare to Nearest Emtricitabine Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | CIPLA LIMITED | $2.0M | 40 | 10 | $50.0K |
| 10 | EMCURE PHARMACEUTICALS LIMITED | $1.5M | 52 | 20 | $28.5K |
| 9 | STRIDES PHARMA SCIENCE LIMITED ★ | $650.0K | 13 | 6 | $50.0K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $500.0K | 10 | 3 | $50.0K |
| 12 | LAURUS LABS LIMITED | $400.0K | 8 | 6 | $50.0K |
Strides Pharma Science Limited ranks #9 among 141 Indian Emtricitabine exporters. Average shipment value of $50.0K compared to the market average of $363.2K. The closest competitors by value are CIPLA LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Emtricitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 524 | 23.9% |
| SAHAR AIR | 469 | 21.4% |
| Bombay Air | 166 | 7.6% |
| DELHI AIR | 153 | 7.0% |
| DELHI AIR CARGO ACC (INDEL4) | 141 | 6.4% |
| NHAVA SHEVA SEA (INNSA1) | 60 | 2.7% |
| Bombay Air Cargo | 55 | 2.5% |
| HYDERABAD ACC (INHYD4) | 54 | 2.5% |
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Emtricitabine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Emtricitabine, top products include Ibuprofen, Rosuvastatin, Gabapentin, Vancomycin, Prednisone. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Emtricitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Emtricitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching Strides Pharma Science Limited exporting Emtricitabine, covering 8 formulations to 6 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 117+ countries, 493+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Emtricitabine Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Emtricitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Emtricitabine Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Emtricitabine. For current shipment-level data, contact TransData Nexus.